The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
Merriman’s research interests also include outcomes in gout, especially severity and drug response. He also applies genetic epidemiological techniques to understanding the causal relationships in gout ...
“There is an unmet clinical need in the prevention of gout in people with a propensity to flare and better treatment of the flare. Current treatments can be toxic if used in a prolonged way. It is ...